Gastric or Esophagogastric Junction Adenocarcinoma
4 clinical trials · Condition
◉ Watch Gastric or Esophagogastric Junction Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer (NCT05180734) | Shanghai Junshi Bioscience Co., Ltd. | 2022-02-10 |
Track Gastric or Esophagogastric Junction Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.